Clinical Trial Update: EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating EBV-specific cytokine-secreting TCR-T cells for EBV-positive metastatic or refractory nasopharyngeal carcinoma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• EBV-specific cytokine-secreting TCR-T cells

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Nasopharyngeal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED